The Mosaic Company delivered a third-quarter loss far deeper than Wall Street had braced for. It posted a loss of $0.19 per share against a consensus estimate of -$0.03 and an Earnings Whisper number of -$0.05, a 280.0% miss. Earnings fell 118.3% year over year, swinging from a year-ago profit to a loss. Revenue held up better. Sales of $3.101 billion edged past the $3.08 billion consensus by 0.7%, though they still declined 10.2% from last year. That split is the central tension of the quarter. Top-line demand is proving sturdier than feared, but cost inflation, particularly in sulfur, and repeated production curtailments are crushing the earnings line. Management told investors the worst is still one quarter away.

The quality of the quarter deserves scrutiny. The press release itself offered little beyond a pointer to supplemental materials, so the real story came from the call. There, the picture was one of an operating footprint still shrinking. Phosphate production plans have been cut at nearly every turn this year. The company started from a target of at least 7 million tons, moved to partial curtailments, then fully idled Louisiana with Bartow at roughly 40%. Now mining is also idled at South Fort Meade and Miskimayo, and the Florida operating rate has fallen to the low-to-mid 60% range from the mid-70s cited last quarter. Potash added its own problem. Third-quarter production fell short because of anomalous ore and salt-dome conditions plus heavier turnarounds, which forced a cut to fourth-quarter potash sales volume guidance with inventories already low.

The near-term margin outlook is the bears' strongest ammunition. Management explicitly flagged the fourth quarter as the EBITDA trough, especially in phosphate. Expensive sulfur bought earlier is still flowing through inventory, with Q4 sulfur cost of goods guided to $800-850 per ton versus $715 realized in Q3. That compresses the realized stripping margin to the mid-$300s per ton, down from $422 in Q2 and roughly $400-plus in Q1. The CFO said both phosphate and company-wide EBITDA will decline sequentially. There is also a deferred bill coming due. Sustaining capex and gypstack and clay-settling spending that was pushed out will return once idled operations restart. Management offered no restart timetable and tied any restart to sustained lower spot sulfur and healthier stripping margins.

Yet the call preserved a credible recovery narrative, and management's tone was noticeably more constructive than in recent quarters. The Q4 U.S. Gulf sulfur contract was signed at $615 per ton, down from $705 in Q3 and well below a market near $1,100. That sets up meaningful cost relief once current inventory clears. North American fall phosphate demand came in "much stronger than anticipated," and fourth-quarter phosphate tons are largely sold out, a sharp reversal from the roughly 20% application cut forecast on the prior call. Brazil is showing green shoots, with Mato Grosso farm economics at a three-year high and phosphate inventories low, although customer credit remains constrained.

Potash looks more favorable on several fronts:

• Baltic logistics constraints are removing about 1.5 million tons of Russian and Belarusian exports in Q4.
• Global demand sits near a record of roughly 75 million tons.
• India's 2027 contract talks are starting early, while China builds strategic reserves.
• Esterhazy set October production records and is on pace for more than 5 million tons in 2027.

Cost discipline is the other quiet positive:

• The 2027 capex target now sits below $1 billion, years ahead of a prior 2030 goal and down from $1.5 billion at the start of the year.
• SG&A is targeted below $500 million for 2027.
• Potash cash costs fell $11 per ton sequentially.
• Turnaround costs are down about $100 million year over year.
• The 2027 and 2028 debt maturities have been refinanced, and management expects positive second-half free cash flow.

The market had little patience coming into the print. Shares at $18.42 are down 15.1% since the open following the August report and sit 22.7% below the 200-day moving average of $23.82. Investor sentiment, already negative, slipped modestly from -0.13 to -0.18, a deterioration rather than a capitulation. The Earnings Whispers trend signals remain mostly negative, with price, momentum, and AVWAP readings all pointing lower. Investors clearly were not positioned for a clean beat, but the depth of the miss gives skeptics little reason to change their stance quickly.

The bottom line is that Mosaic's quarter was weaker than expected on earnings, and management has told investors the fourth quarter will be weaker still. The setup has nonetheless shifted. Cheaper contracted sulfur, firmer phosphate demand, supportive potash supply dynamics, and a leaner cost and capex base give the company a plausible path to margin recovery in 2027. That path still depends on sulfur staying low, idled capacity restarting without a clear schedule, and deferred spending not eroding the gains. Until the trough quarter is behind it, the burden of proof remains on Mosaic.